Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Cytek Biosciences, Inc. (CTKB) had Non-Operating Income/Expense of $10.54M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$201.49M |
|
$-66.54M |
|
$97.03M |
|
$104.46M |
|
$241.88M |
|
$-40.38M |
|
|
Non-Operating Income/Expense |
$10.54M |
$-29.84M |
|
$-29.84M |
|
$-66.54M |
|
$-66.54M |
|
$-66.54M |
|
$-66.54M |
|
$-40.38M |
|
$-28.41M |
|
127.75M |
|
127.75M |
|
$-0.52 |
|
$-0.52 |
|
| Balance Sheet Financials | |
$392.00M |
|
$18.01M |
|
$69.55M |
|
$461.54M |
|
$77.80M |
|
$0.53M |
|
$42.00M |
|
$119.80M |
|
$341.74M |
|
$308.22M |
|
$341.74M |
|
128.55M |
|
| Cash Flow Statement Financials | |
$-4.69M |
|
$10.12M |
|
$-13.43M |
|
$98.75M |
|
$90.85M |
|
$-7.89M |
|
$24.59M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.04 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
51.84% |
|
-20.04% |
|
-20.04% |
|
-14.10% |
|
-14.81% |
|
-33.02% |
|
$-8.52M |
|
-- |
|
-- |
|
-- |
|
0.44 |
|
2.00 |
|
3.22 |
|
113.23 |
|
-19.47% |
|
-21.59% |
|
-14.42% |
|
-19.44% |
|
$2.66 |
|
$-0.07 |
|
$-0.04 |
|